Impact of an add-on strategy of the C-C chemokine receptor 5 (CCR5) antagonist maraviroc on hepatic inflammation in HIV-infected individuals with non-alcoholic steatohepatitis: a paired-liver biopsy proof-of-concept study - Ingiliz, P; Maurice, J; Shimakawa, Y; Grunwald, S; Tsochatzis, E; Bhagani, S; Boesecke, C; Rockstroh, JK; Anyanechi, M; Kidd, O; Garvey, L; Khamri, W; et al. (Wiley, 2021)